BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Honda K, Seike M, Murakami K. Benefits of nucleos(t)ide analog treatments for hepatitis B virus-related cirrhosis. World J Hepatol 2015; 7(22): 2404-2410 [PMID: 26464756 DOI: 10.4254/wjh.v7.i22.2404]
URL: https://www.wjgnet.com/1948-5182/full/v7/i22/2404.htm
Number Citing Articles
1
Zheng-xin Li, Zhi-min Zhao, Ping Liu, Qing-shan Zheng, Cheng-hai Liu. Treatment of HBV Cirrhosis with Fuzheng Huayu Tablet (扶正化瘀片) and Entecavir: Design of a Randomized, Double-Blind, Parallel and Multicenter Clinical TrialChinese Journal of Integrative Medicine 2021; 27(7): 509 doi: 10.1007/s11655-020-3257-6
2
Ryan Taylor Anderson, Seng Gee Lim, Poonam Mishra, Filip Josephson, Eric Donaldson, Bruce Given, Veronica Miller. Challenges, Considerations, and Principles to Guide Trials of Combination Therapies for Chronic Hepatitis B VirusGastroenterology 2019; 156(3): 529 doi: 10.1053/j.gastro.2018.11.062
3
Sammy Saab, Ping-yu Chen, Clara E. Saab, Myron J. Tong. The Management of Hepatitis B in Liver Transplant RecipientsClinics in Liver Disease 2016; 20(4): 721 doi: 10.1016/j.cld.2016.06.004
4
Chueh-Ling Liu, Cheng-Kun Wu, Hon-Yi Shi, Wei-Chen Tai, Chih-Ming Liang, Shih-Cheng Yang, Keng-Liang Wu, Yi-Chun Chiu, Seng-Kee Chuah. Medical expenses in treating acute esophageal variceal bleedingMedicine 2016; 95(28): e4215 doi: 10.1097/MD.0000000000004215
5
M.‐L. Wang, E.‐Q. Chen, D.‐M. Zhang, L.‐Y. Du, L.‐B. Yan, T.‐Y. Zhou, X.‐Z. Lei, B.‐J. Lei, J.‐J. Lu, J. Liao, H. Tang. Efficacy and safety of three adefovir‐based combination therapies in HBeAg‐positive chronic hepatitis B patients with suboptimal response to adefovir monotherapyJournal of Viral Hepatitis 2017; 24(S1): 21 doi: 10.1111/jvh.12792
6
Ahmad Hormati, Maryam Jameshorani, Seyed Saeed Sarkeshikian , Mansureh Molaei, Mahdi Jahangiri, Mohammad Reza Ghadir. Effects of Atorvastatin Alongside Conventional Medical Treatment on Liver Fibrosis and Dysfunction in Patients with Chronic Hepatitis B: A Double-Blinded Clinical TrialHepatitis Monthly 2019; (In Press) doi: 10.5812/hepatmon.84656
7
Aunchalee Jaroenlapnopparat, Maneerat Chayanupatkul, Pisit Tangkijvanich. Novel viral markers and the prediction of off‐treatment relapse in chronic hepatitis B patients: A systematic reviewJournal of Gastroenterology and Hepatology 2021; 36(9): 2349 doi: 10.1111/jgh.15516
8
Yunqi Liu, Ximei Wang, Fuping Xu, Dengren Li, Huimin Yang, Nan Sun, Yu-Chen Fan, Xiangdong Yang. Risk Factors of Chronic Kidney Disease in Chronic Hepatitis B: A Hospital-based Case-control Study from ChinaJournal of Clinical and Translational Hepatology 2022; 10(2): 238 doi: 10.14218/JCTH.2021.00082
9
Experimental and Clinical Transplantation 2017; 15(2) doi: 10.6002/ect.2016.0195
10
Christine Sempoux, Maria Guido, Romil Saxena. Practical Hepatic Pathology: a Diagnostic Approach2018; : 679 doi: 10.1016/B978-0-323-42873-6.00041-X